DMT310-005 Topical in the Treatment of Acne Rosacea
Status:
Not yet recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The objective is to evaluate the tolerability, safety, and efficacy of DMT310 topical powder
mixed with diluent in male and female patients with moderate to severe facial acne rosacea.